SNDX Next Earnings Date Notes

— Syndax Pharmaceuticals (NASDAQ: SNDX) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer. The company’s lead candidates include revumenib, a menin inhibitor being developed for genetically defined acute leukemias, and axatilimab, an anti-CSF-1R antibody targeting chronic graft-versus-host disease (cGVHD). Syndax operates in a highly dynamic segment of the biotech industry, where success hinges on clinical milestones, regulatory progress, and the strength of its R&D pipeline. For investors listening to the next earnings call, key business metrics to monitor include cash runway (how long current funding is projected to last), updates on clinical trial enrollment & timelines for key readouts, partnership developments (notably with Incyte for axatilimab), and any regulatory submissions or feedback from the FDA. Progress toward pivotal trial results, market potential estimates for lead programs, and management discourse on commercialization strategy are also critical indicators of long-term value creation. Tracking these metrics will help you best gauge whether Syndax is on track for sustainable growth and future market impact. The next projected earnings date for SNDX is 11/2/2026 after close (stay tuned for a confirmed earnings date once announced).

SNDX Next Earnings Date FAQ

On this page we presented the SNDX Next Earnings Date information for Syndax Pharmaceuticals along with recent past earnings dates. For Q2 of 2026, SNDX reported earnings of -0.550/share, with the earnings report taking place on 8/4/2026. For Q1 of 2026, SNDX reported earnings of -0.480/share, with the earnings report taking place on 4/30/2026. For Q4 of 2025, SNDX reported earnings of -0.780/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, SNDX reported earnings of -0.700/share, with the earnings report taking place on 11/3/2025. For Q2 of 2025, SNDX reported earnings of -0.830/share, with the earnings report taking place on 8/4/2025. Based on these past earnings dates, the projected next earnings date for SNDX is 11/2/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Syndax Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Syndax Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Syndax Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next SNDX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up SNDX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the SNDX next earnings date.